These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17613982)

  • 1. Sensitivity of the Halstead Category Test factor scores to brain damage.
    Allen DN; Caron JE; Duke LA; Goldstein G
    Clin Neuropsychol; 2007 Jul; 21(4):638-52. PubMed ID: 17613982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Halstead Category Test a multidimensional instrument?
    Allen DN; Goldstein G; Mariano E
    J Clin Exp Neuropsychol; 1999 Apr; 21(2):237-44. PubMed ID: 10425520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malingering indexes for the Halstead Category Test.
    Forrest TJ; Allen DN; Goldstein G
    Clin Neuropsychol; 2004 May; 18(2):334-47. PubMed ID: 15587679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of the Halstead and Wechsler Test Batteries to brain damage: Evidence from Reitan's original validation sample.
    Loring DW; Larrabee GJ
    Clin Neuropsychol; 2006 Jun; 20(2):221-9. PubMed ID: 16690543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the Children's Category Test-Level 1 in a clinical sample with heterogeneous forms of brain dysfunction.
    Allen DN; Knatz DT; Mayfield J
    Arch Clin Neuropsychol; 2006 Oct; 21(7):711-20. PubMed ID: 17071362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the Halstead-Reitan Battery to diagnose brain damage: a comparison of the predictive power of traditional techniques to Rohling's Interpretive Method.
    Rohling ML; Williamson DJ; Miller LS; Adams RL
    Clin Neuropsychol; 2003 Nov; 17(4):531-43. PubMed ID: 15168917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the Halstead Category Test.
    Lopez MN; Charter RA; Newman RJ
    Clin Neuropsychol; 2000 May; 14(2):157-61. PubMed ID: 10916189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor analysis and matrix invariance of the HRNB-C category test.
    Kelly MD; Kundert DK; Dean RS
    Arch Clin Neuropsychol; 1992 Oct; 7(5):415-8. PubMed ID: 14591276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia?
    Standish TI; Molloy DW; Cunje A; Lewis DL
    Int J Geriatr Psychiatry; 2007 Mar; 22(3):189-94. PubMed ID: 16977680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to brain dysfunction of the Halstead-Reitan vs an ability-focused neuropsychological battery.
    Larrabee GJ; Millis SR; Meyers JE
    Clin Neuropsychol; 2008 Sep; 22(5):813-25. PubMed ID: 18756388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New scores for the Category Test: measures of interference for subtests 5 and 6.
    Webster JS; Lopez MN
    Clin Neuropsychol; 2006 Dec; 20(4):678-94. PubMed ID: 16980254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing to detect brain damage: an alternative to what may no longer be useful.
    Mapou RL
    J Clin Exp Neuropsychol; 1988 Mar; 10(2):271-8. PubMed ID: 3350925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of the children's category test level 2 to brain dysfunction.
    Bello DT; Allen DN; Mayfield J
    Arch Clin Neuropsychol; 2008 May; 23(3):329-39. PubMed ID: 18280106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for neuropsychological impairment using Reitan and Wolfson's preliminary neuropsychological test battery.
    Horwitz JE; Lynch JK; McCaffrey RJ; Fisher JM
    Arch Clin Neuropsychol; 2008 Jul; 23(4):393-8. PubMed ID: 18395407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Moss Attention Rating Scale for traumatic brain injury: further explorations of reliability and sensitivity to change.
    Whyte J; Hart T; Ellis CA; Chervoneva I
    Arch Phys Med Rehabil; 2008 May; 89(5):966-73. PubMed ID: 18452747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three short forms of the Category Test.
    Sherrill RE
    J Clin Exp Neuropsychol; 1985 Jun; 7(3):231-8. PubMed ID: 3998088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral Dyscontrol Scale deficits among traumatic brain injury patients, part I: Validation with nongeriatric patients.
    Leahy B; Suchy Y; Sweet JJ; Lam CS
    Clin Neuropsychol; 2003 Nov; 17(4):474-91. PubMed ID: 15168913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.